Arq, Inc.

ARQ Nasdaq CIK: 0001515156

Company Information

Industry Miscellaneous Chemical Products
SIC Code 2890
Entity Type operating
SEC Category Accelerated filerSmaller reporting company
Business Address 8051 E. MAPLEWOOD AVE., STE 210, GREENWOOD VILLAGE, CO, 80111
Mailing Address 8051 E. MAPLEWOOD AVE., STE 210, GREENWOOD VILLAGE, CO, 80111
Phone 720-598-3500
Fiscal Year End 1231
EIN 275472457

Financial Overview

FY2024

$284.37M
Total Assets
$67.09M
Total Liabilities
$45.36M
Cash & Equivalents
$-0.14
EPS

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events January 29, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment January 28, 2026 View on SEC
8-K Current report of material events December 11, 2025 View on SEC
4 Insider stock transaction report November 13, 2025 View on SEC
4 Insider stock transaction report November 13, 2025 View on SEC
4 Insider stock transaction report November 12, 2025 View on SEC
8-K Current report of material events November 5, 2025 View on SEC
10-Q Quarterly financial report November 5, 2025 View on SEC
4 Insider stock transaction report October 6, 2025 View on SEC
4 Insider stock transaction report September 19, 2025 View on SEC

Material Events

8-K Financial Distress January 29, 2026
High Impact
  • Arq, Inc. secured its third amendment to the Revolving Credit Agreement with MidCap Funding IV Trust.
  • The minimum cash requirement for Arq has been temporarily reduced from $5 million to $2 million.
View Analysis
8-K Financial Distress December 11, 2025
High Impact
  • Arq, Inc. entered into a Second Amendment to its credit agreement with MidCap Funding IV Trust on December 9, 2025.
  • The amendment updated the calculation method for Arq's borrowing availability under its credit line.
View Analysis

Related Companies

Companies in the same industry (SIC: 2890)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.